Novo cuts Wegovy prices, but doctors still see cost challenges for patients
By TOM MURPHY, Associated Press Health Writer
Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without insurance.
Related Articles
-
Future data centers are driving up forecasts for energy demand. States want proof they’ll get built -
Man charged with murder in shooting of Oakland football coach and ‘Last Chance U’ star John Beam -
President Donald Trump unveils ‘FIFA Pass’ to help World Cup travelers get their visas faster -
America will celebrate its 250th birthday next year. There’s a commemorative ornament for it -
OJ Simpson’s estate accepts $58M claim from Goldman family but any payment would be a fraction
The drugmaker said Monday that it has started selling higher doses of the injectable obesity treatment for $349 a month to patients paying the full bill. That’s down from $499, and in line with terms of a drug pricing agreement outlined earlier this month by President Donald Trump’s administration.